Latest News about NVO
Recent news which mentions NVO
From Motley Fool
Jim Cramer Identifies Eight Companies Eyeing Trillion-Dollar Club — Elon Musk's Tesla, Eli Lilly Top Contenders
July 11, 2024
From Benzinga
3 Pharma Stocks That Could Make Your Grandchildren Rich
July 10, 2024
From InvestorPlace
Only 25% Patients Stick With Novo Nordisk's Wegovy Or Ozempic After 2 Years, A Study Shows; Company Calls Data Insufficient
July 10, 2024
From Benzinga
From InvestorPlace
From InvestorPlace
3 Stocks With the Potential to 10X Your Money
July 09, 2024
From InvestorPlace
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
July 09, 2024
From Motley Fool
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
July 09, 2024
From Benzinga
3 Overlooked Giants-in-the-Making for Patient Investors
July 08, 2024
From InvestorPlace
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
July 07, 2024
From Benzinga
The 7 Best Under $10 Stocks to Buy in July 2024
July 06, 2024
From InvestorPlace
GLP-1 Treatments Such As Wegvoy, Mounjaro Cut Obesity-Related Cancer Risks, Study Finds
July 05, 2024
From Benzinga
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
July 05, 2024
From Benzinga
Did Vertex Pharmaceuticals Just Invent the Next Ozempic?
July 05, 2024
From Motley Fool
From Benzinga
The 3 Best Healthcare Stocks to Buy in July 2024
July 04, 2024
From InvestorPlace
From Benzinga
Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
July 03, 2024
From Benzinga
The 7 Best Stocks to Buy in July 2024
July 03, 2024
From InvestorPlace
Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs
July 02, 2024
From Benzinga
From InvestorPlace
3 Breakout Biotech Stocks on Track to Double by 2032
July 01, 2024
From InvestorPlace
Surprise! Novo Nordisk's Wegovy Just Achieved Another Milestone. Here's What You Need to Know.
June 30, 2024
Tickers
NVO
From Motley Fool
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy
June 29, 2024
From Motley Fool
This Is Massive News for Eli Lilly Investors
June 29, 2024
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.